신경퇴행성 질환에서의 유효성 평가

신경퇴행성 질환에는 알츠하이머병(AD), 근위축측삭경화증(amyotrophic lateral sclerosis, ALS), 파킨슨병(PD), 헌팅턴병(HD) 등이 있는데, 신경세포의 구조나 기능이 소실되어 발병하는 비가역적 질환입니다. 우리가 개발하여 지적재산권(IP)을 소유하고 있는 FAD4T(AD), SNCA(PD), TDP43(ALS), SOD1(ALS), HTT(HD) 마우스는 모리스 수중 미로(Morrise water maze), Y형 미로, 보행 분석을 비롯한 다양한 시험을 수행할 수 있는 행동 분석 플랫폼이 됩니다. 젬파마텍은 여러 신경퇴행성 질환의 치료제 개발을 가속화하기 위해 이들 질환에서의 유효성 평가 서비스도 추가로 제공합니다.

TALK WITH OUR EXPERTS

GemPharmatech is committed to protecting and respecting your privacy, and we'll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please click below to say how you would like us to contact you:

In order to provide you with the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please click the checkbox below.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.